Declan Noone

1.1k citations

53 papers · 709 indexed · h-index 16

Impact in

Hematology top 2%
- Hemophilia Treatment and Research
- Platelet Disorders and Treatments
- Blood Coagulation and Thrombosis Mechanisms
- Chronic Myeloid Leukemia Treatments
Genetics top 10%
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Virus-based gene therapy research

Papers in ⓘ

Hematology 44
- Hemophilia Treatment and Research 43
- Platelet Disorders and Treatments 7
- Chronic Myeloid Leukemia Treatments 6
- Blood Coagulation and Thrombosis Mechanisms 5
Genetics 6
- Myeloproliferative Neoplasms: Diagnosis and Treatment 4
- Virus-based gene therapy research 3

Co-authors: Brian O’Mahony (30 shared papers)Lucia Prihodová (4 shared papers)Paul Giangrande (3 shared papers)Mark W. Skinner (14 shared papers)Flora Peyvandi (7 shared papers)David Page (12 shared papers)Rezan A. Kadir (2 shared papers)Michelle Lavin (2 shared papers)
Journals: Haemophilia (25 papers)Blood (7 papers)Journal of Thrombosis and Haemostasis (2 papers)Research and Practice in Thrombosis and Haemostasis (2 papers)Orphanet Journal of Rare Diseases (2 papers)
Partner nations: United Kingdom Ireland United States

In The Last Decade

Declan Noone

49 papers receiving 664 citations

Peers

Countries citing papers authored by Declan Noone

Since Specialization

Citations

This map shows the geographic impact of Declan Noone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Declan Noone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Declan Noone more than expected).

Fields of papers citing papers by Declan Noone

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Declan Noone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Declan Noone. The network helps show where Declan Noone may publish in the future.

Co-authors

The 25 scholars most cited alongside Declan Noone, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Declan Noone Line = papers co-authored together Declan Noone links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Haemophilia care in Europe – a survey of 35 countries Haemophilia ·Brian O’Mahony, Declan Noone, Paul Giangrande, Lucia Prihodová	2013	56
2	European principles of care for women and girls with inherited bleeding disorders Haemophilia ·Karin P. M. van Galen, Michelle Lavin, Naja Skouw‐Rasmussen, Kathelijn Fischer, Declan Noone, Debra Pollard, Eveline P. Mauser‐Bunschoten, Kate Khair, Keith Gomez, Ellen van Loon, Catherine Bagot, Petra Elfvinge, Roseline d’Oiron, Rezan A. Kadir	2021	53
3	Treatment for life for severe haemophilia A– A cost‐utility model for prophylaxis vs. on‐demand treatment Haemophilia ·Albert Farrugia, Josephine Cassar, Mary Clare Kimber, Megha Bansal, Kathelijn Fischer, G. Auserswald, Brian O’Mahony, Keith Tolley, Declan Noone, Sonia Balboni	2013	49
4	A survey of the outcome of prophylaxis, on‐demand treatment or combined treatment in 18–35‐year old men with severe haemophilia in six countries Haemophilia ·Declan Noone, Brian O’Mahony, Jitse P. van Dijk, Lucia Prihodová	2012	44
5	Delivery of AAV‐based gene therapy through haemophilia centres—A need for re‐evaluation of infrastructure and comprehensive care: A Joint publication of EAHAD and EHC Haemophilia ·Wolfgang Miesbach, Pratima Chowdary, Michiel Coppens, Daniel P. Hart, Víctor Jiménez‐Yuste, Robert Klamroth, Michael Makris, Declan Noone, Flora Peyvandi	2021	42
6	Barriers and challenges faced by women with congenital bleeding disorders in Europe: Results of a patient survey conducted by the European Haemophilia Consortium Haemophilia ·Declan Noone, Naja Skouw‐Rasmussen, Michelle Lavin, Karin P. M. van Galen, Rezan A. Kadir	2019	39
7	The Patient Reported Outcomes, Burdens and Experiences (PROBE) Project: development and evaluation of a questionnaire assessing patient reported outcomes in people with haemophilia Pilot and Feasibility Studies ·Mark W. Skinner, Chatree Chai‐Adisaksopha, Randall Curtis, N. Frick, Michael B. Nichol, Declan Noone, Brian O’Mahony, David Page, Jeffrey S. Stonebraker, Alfonso Iorio	2018	36
8	Hemophilia treatment in 2021: Choosing the”optimal” treatment using an integrative, patient-oriented approach to shared decision-making between patients and clinicians Blood Reviews ·Cédric Hermans, Declan Noone, Gary Benson, G. Dolan, Hermann Eichler, Víctor Jiménez‐Yuste, Christoph Königs, Sébastien Lobet, Debra Pollard, Silva Zupančić‐Šalek, Maria Elisa Mancuso	2021	32
9	Hemorrhagic and thrombotic adverse events associated with emicizumab and extended half-life factor VIII replacement drugs: EudraVigilance data of 2021 Journal of Thrombosis and Haemostasis ·Maria Abbattista, Alessandro Ciavarella, Declan Noone, Flora Peyvandi	2023	27
10	Non‐severe haemophilia: Is it benign? – Insights from the PROBE study Haemophilia ·Chatree Chai‐Adisaksopha, Declan Noone, Randall Curtis, Neil Frick, Michael B. Nichol, Federico Germini, Brian O’Mahony, David Page, Jeffrey S. Stonebraker, Mark W. Skinner, Alfonso Iorio	2020	25
11	Haemophilia care in Europe: a survey of 19 countries Haemophilia ·Brian O’Mahony, Declan Noone, Paul Giangrande, Lucia Prihodová	2010	24
12	Assessing the value of orphan drugs using conventional cost-effectiveness analysis: Is it fit for purpose? Orphanet Journal of Rare Diseases ·Maarten J. Postma, Declan Noone, Mark H. Rozenbaum, John A. Carter, Marc Botteman, Elisabeth Fenwick, Louis P. Garrison	2022	22
13	Gene therapy to cure haemophilia: Is robust scientific inquiry the missing factor? Haemophilia ·Glenn F. Pierce, Radosław Kaczmarek, Declan Noone, Brian O’Mahony, David Page, Mark W. Skinner	2020	19
14	Psychometric properties of the Patient Reported Outcomes, Burdens and Experiences (PROBE) questionnaire BMJ Open ·Chatree Chai‐Adisaksopha, Mark W. Skinner, Randall Curtis, Neil Frick, Michael B. Nichol, Declan Noone, Brian O’Mahony, David Page, Jeffrey S. Stonebraker, Lehana Thabane, Mark Crowther, Alfonso Iorio	2018	19
15	Survey of coagulation factor concentrates tender and procurement procedures in 38 European Countries Haemophilia ·Brian O’Mahony, Declan Noone, Lucia Prihodová	2015	18
16	Test‐retest properties of the Patient Reported Outcomes, Burdens and Experiences (PROBE) questionnaire and its constituent domains Haemophilia ·Chatree Chai‐Adisaksopha, Mark W. Skinner, Randall Curtis, Neil Frick, Michael B. Nichol, Declan Noone, Brian O’Mahony, David Page, Jeffrey S. Stonebraker, Lehana Thabane, Mark Crowther, Alfonso Iorio	2018	16
17	Understanding minimum and ideal factor levels for participation in physical activities by people with haemophilia: An expert elicitation exercise Haemophilia ·Antony P. Martin, Tom Burke, Sohaib Asghar, Declan Noone, Gabriel Pedra, Jamie O’Hara	2020	15
18	Hemophilia gene therapy: first, do no harm Journal of Thrombosis and Haemostasis ·Leonard A. Valentino, Radosław Kaczmarek, Glenn F. Pierce, Declan Noone, Brian O’Mahony, David Page, Dawn Rotellini, Mark W. Skinner	2023	11
19	Exploring regional variations in the cross‐cultural, international implementation of the Patient Reported Outcomes Burdens and Experience (PROBE) study Haemophilia ·Chatree Chai‐Adisaksopha, Mark W. Skinner, Randall Curtis, Neil Frick, Michael B. Nichol, Declan Noone, Brian O’Mahony, David Page, Jeffrey S. Stonebraker, Lehana Thabane, Mark Crowther, Alfonso Iorio	2019	11
20	Clinical attributes and treatment characteristics are associated with work productivity and activity impairment in people with severe haemophilia A Haemophilia ·Jamie O’Hara, Declan Noone, Mohit Jain, Gabriel Pedra, Sarah Landis, Charles R. Hawes, Tom Burke, Charlotte Camp	2021	11

About Declan Noone

Declan Noone is a scholar working on Hematology, Genetics, Hepatology, Oncology and Economics and Econometrics, having authored 53 papers that have together received 709 indexed citations. Recurring topics across this work include Hemophilia Treatment and Research (43 papers), Platelet Disorders and Treatments (7 papers), Chronic Myeloid Leukemia Treatments (6 papers), CAR-T cell therapy research (5 papers), Blood Coagulation and Thrombosis Mechanisms (5 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers), Virus-based gene therapy research (3 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). The work is most often cited by research in Hematology (593 citations), Genetics (91 citations), Obstetrics and Gynecology (22 citations), Oncology (71 citations) and Genetics (68 citations). Declan Noone has collaborated with scholars based in United Kingdom, Ireland and United States. Frequent co-authors include Brian O’Mahony, Lucia Prihodová, Paul Giangrande, Mark W. Skinner, Flora Peyvandi, David Page, Rezan A. Kadir, Michelle Lavin, Karin P. M. van Galen and Randall Curtis. Their work appears in journals such as Haemophilia, Blood, Journal of Thrombosis and Haemostasis, Research and Practice in Thrombosis and Haemostasis and Orphanet Journal of Rare Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact